Levofloxacin Hemihydrate Prices to tumble in Q3 in the U.S., here is the reason why

Key Highlights

• Levofloxacin Hemihydrate Price is expected to trend downward across Q* ****.
• Extension of the U.S.-China tariff deal until November **, ****, stabilized trade flows and avoided sudden duty hikes.
• Sufficient supply availability of Levofloxacin Hemihydrate ensured no shortages, tipping the market toward oversupply conditions.
• Market sentiment stayed bearish, with distributors avoiding aggressive buying of Levofloxacin Hemihydrate, expecting better deals later.
• Outlook for Q* **** suggests possible stabilization from winter demand and post–Golden Week supply adjustments.

The U.S. market is expected to witness subdued Levofloxacin Hemihydrate offtake during Q*. Hospitals and clinics, being the major buyers, are likely to cut purchases, while flu prescriptions reduce during summer seasons overall, resulting in slowing down the use of antibiotics. The seasonal downturn is anticipated to generate a weaker demand pull of Levofloxacin Hemihydrate from end-users, not allowing any price increase. Distributors are also expected to maintain a cautious stance, avoiding...